ANI Pharmaceuticals (ANIP) 10-Q2015 Q1 Quarterly report

Filed: 5 May 15, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: Acetate, affiliate, affiliated, APIC, BioSatite, bond, calendar, consecutive, counterparty, coverage, diversify, embedded, equal, Etodolac, event, extent, feature, Flecainide, grow, guaranteed, hedge, holder, indexed, institution, manner, mature, maturity, Methazolamide, movement, Overlay, preceding, registered, residual, scheduled, simplify, simultaneously, specifically, strike, synthetically, theoretical, traded, trademark, trading, underlying, underwriting, vary, written

Removed: abuse, acquiree, acquiring, advisory, al, appeal, appellate, applying, apportioning, artificially, attractive, automatically, averaging, bioequivalent, board, caption, carryforward, Center, Chancery, charge, Chief, Circuit, closed, collaboration, commercial, communication, compensatory, competitor, complaint, comprised, conference, confirming, connection, consisted, consulting, Cook, copy, corporate, corporation, counsel, County, covering, dated, deductible, Department, derivative, developed, discounted, distribute, distributing, Division, duty, efficacy, elimination, enabled, enrichment, equitable, established, expensed, experience, expert, false, female, fiduciary, file, filing, flow, Fluvoxamine, forma, formally, gave, gel, governance, hard, high, identical, incomeavailable, incurred, inflating, injunctive, inspection, installment, iscomputedby, iv, Jerome, judge, July, jurisdiction, label, Lauria, law, leadership, led, legal, letter, LibiGel, liquid, male, meeting, millionbalance, mismanagement, model, monitoring, netting, nominal, Northern, notice, occurred, occurring, operate, ownership, party, paying, pending, performed, plaintiff, preferred, President, pro, prohibited, projected, punitive, purport, purported, purpose, qualify, range, relief, renamed, renew, renewed, reorganization, replace, represent, requested, requesting, resolution, responsible, revolving, Rule, secure, security, served, shareholder, shareholdersby, situated, slightly, Smaller, Sofgen, soft, sought, Stephen, stockholder, stopped, structured, submission, substantial, taxable, team, telephone, terminated, testosterone, theFinancial, transferred, turn, unjust, volatility, voluntarily, Weinstein, whenwe

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

ANIP similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report on Form 10-Q of ANI Pharmaceuticals, Inc. (the "Company") for the quarterly period ended March 31, 2015 (the "Report") as filed with the Securities and Exchange Commission on the date hereof, the undersigned Chief Executive Officer and Chief Financial Officer of the Company hereby certify that, to such officer’s knowledge:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

This certification is provided solely pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

Dated: May 5, 2015		/s/ Arthur S. Przybyl
		Arthur S. Przybyl
		President and Chief Executive Officer
		(principal executive officer)

Dated: May 5, 2015		/s/ Charlotte C. Arnold
		Charlotte C. Arnold
		Vice President, Finance and
		Chief Financial Officer
		(principal financial officer)

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.